April 23–24 | St. Petersburg

The CIS Orphan Consortium supports the XIII All-Russian Conference with International Participation.
"Current Issues in Preclinical and Clinical Studies of Drugs and Clinical Trials of Medical Devices."

The event will bring together the professional community involved in the development, evaluation, and implementation of drugs and medical technologies.

Format: in-person + online
Venue: Pavlodar State Medical University of St. Petersburg named after I.P. Pavlova
Broadcast and registration: https://congress.1spbgmu.ru/

Focus of the scientific program:

• Theory and practice of preclinical drug safety studies
• Application of real-world clinical practice data from a clinical pharmacology perspective in drug development
• Bioinformatics and molecular modeling methods in drug development
• Preclinical studies of specific activity. Translational models
• Clinical research in psychiatry and narcology
• Pharmacovigilance - current realities in Russia
• Biomedical statistics and data management in preclinical and clinical trials
• Handling personal data in clinical trials
• Clinical trials of new medical devices
• Clinical trials in pediatrics
• Mathematical modeling in preclinical and clinical trials
• Adaptation of the clinical trial quality management system to the new regulatory requirements of ICH GCP R3

More than 800 participants are expected:
experts in clinical research, pharmacoeconomics, pharmacovigilance, as well as specialists in clinical disciplines - from oncology to neurology and cardiology.

The conference agenda is directly related to key issues The CIS Orphan Consortium's main areas of work include the development of clinical trials, the use of RWD, the introduction of innovative therapies, and the improvement of regulatory approaches.

Detailed program and registration:
https://congress.1spbgmu.ru/events/aktualnye-voprosy-doklinicheskih-i-klinicheskih-issledovanij-leka...